AstraZeneca

24

4

qz.com/astrazeneca-cost-savings-program-drug-pipeline-earnings-103026

Credibility B+

Oct 30

AstraZeneca is launching a $1.5 billion cost-savings program to fund its drug pipeline

5 similar articles

7

0

Euronews

AstraZeneca increases profit thanks to cancer drugs, plans major savings program

Oct 31

statnews.com/pharmalot/2026/10/30/astrazeneca-cost-cutting-sun-pharma-facility-problems/

0

STAT Oct 30

Pharmalittle: We’re reading about AstraZeneca cost-cutting, Sun Pharma facility problems, and more

0

Oct 29

AstraZeneca might develop cancer vaccines, CEO Pascal Soriot says

0

Oct 28

AstraZeneca eyes cancer vaccines — but not the personalized kind AstraZeneca's CEO is signaling the pharma giant could enter the cancer vaccine space ... Show more

0

1

reuters.com/legal/litigation/astrazenecas-stomach-cancer-drug-clears-bar-extending-overall-survival-late-2026-10-25/

Oct 25

AstraZeneca's stomach cancer drug extends overall survival, late-stage trial data finds

61

10 3

South China Morning Post

China-made cancer drug to go on sale in US after Americans travel to buy it

Oct 23

31

24

reuters.com/commentary/breakingviews/gsk-is-two-shots-away-clean-bill-health-2026-10-21/

Oct 22

OpinionGSK is two shots away from clean bill of health: One of Europe’s most cheaply valued drugmakers, the £75 bln group run by Luke Miels ⁠is turning a corner ...

0

2

medscape.org/advances/new-era-airway-disease-management-2025a1000j24

Oct 20

A New Era in Airway Disease Management: Advance your skills in managing and treating airway diseases with expert-led insights and clinical best practices.

1

0

Oct 17

AstraZeneca bets $1.5B on AI to crack diseases it couldn't solve alone: After setbacks in both heart and liver disease research ... Show more

8 similar articles

0

1

cnbc.com/2026/10/05/astrazeneca-ceo-says-summit-drug-could-drive-future-cancer-combos.html

Oct 05

AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment

9

1

reuters.com/legal/transactional/astrazeneca-invest-2-billion-summit-therapeutics-cancer-drug-tie-up-2026-09-28/

Oct 05

AstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up: Summit Therapeutics said on Monday that British drugmaker AstraZeneca would ...

Vietnam's healthcare spending forecast to reach $34.1bn by 2028

9

4

news.tuoitre.vn Oct 03

2

0

The Expanding Role of Nonsteroidal MRAs Across the CKM Continuum

Sep 29

12

1

Oct 01

Ready to modernize your IgAN care strategies? Check out our latest interactive release: "The IgA Nephropathy Clinical Crossroads: Simulated Encounters for ... Show more

IgA Nephropathy

6

1

Investor's Business Daily

Sep 30

Explore new content focused on recognizing uncontrolled moderate to severe asthma and identifying when referral or treatment escalation may be appropriate ... Show more

A New Era in Airway Disease Management

3 similar articles

3

2

D

Sep 29

AstraZeneca Digs $2 Billion Out Of Its Coffers For Summit Deal, Taking On Bristol, Pfizer, Merck

investors.com/news/technology/summit-therapeutics-stock-astrazeneca-investment/

yicaiglobal.com/news/chinas-akeso-soars-as-astrazeneca-backs-cancer-drug-partner-summit-with-usd2-billion

4

0

yicaiglobal.com Sep 29

China's Akeso Soars as AstraZeneca Backs Cancer Drug Partner Summit With USD2 Billion

3

0

TimesLIVE

deraktionaer.de/artikel/pharma-biotech/dividenden-garant-astrazeneca-milliarden-dollar-wette-biotech-aktie-schiesst-hoch-20409754.html

Sep 29

Summit soars after $2bn investment from AstraZeneca for cancer therapies: Summit to test dual cancer therapies in major pharma alliance

0

Sep 29

Dividend guarantor AstraZeneca: Billion-dollar bet - | Biotech stock soars: AstraZeneca invests $2 billion in Summit Therapeutics.

statnews.com/2026/09/29/biotech-news-astrazeneca-invests-2-billion-in-summit-therapeautics/

2

0

STAT Sep 29

AstraZeneca invests $2 billion in Summit Therapeutics: Today's biotech news includes results for UniQure’s experimental Huntington’s gene therapy ...

statnews.com/pharmalot/2026/09/29/novo-licenses-obesity-pill-from-china-merck-pulls-antibiotic/

0

STAT Sep 29

Pharmalittle: We’re reading about Novo licensing a Chinese obesity pill, Merck pulling an antibiotic, and more

0

Sep 29

AstraZeneca takes $2bn stake in cancer-drug maker Summit Therapeutics: The Cambridge company will partner with the US drug developer on clinical trials with ...

thetimes.com/business/companies-markets/article/astrazeneca-2bn-share-in-summit-therapeutics-cancer-drug-maker-fwv9jjgwc

barrons.com/articles/summit-therapeutics-stock-astrazeneca-cancer-drug-d070fe4d

0

Barron's Sep 29

Summit Therapeutics Stock Surges After AstraZeneca Reveals $2 Billion Investment: The deal would give AstraZeneca exposure to a promising cancer treatment ...

wallstreet-online.de/nachricht/21432528-krebsmedikament-fokus-astrazeneca-durchbruch-us-behoerde-beschleunigt-wichtiges-verfahren

0

wotwitt Sep 25

OpinionAstraZeneca on the verge of a breakthrough? US agency speeds up important process

statnews.com/pharmalot/2026/09/25/reticent-fda-commish-nominee-novo-deal/

2

0

STAT Sep 25

Pharmalittle: We’re reading about a reticent FDA commish nominee, a Novo deal, and more

0

Sep 21

Evolving Therapeutic Strategies for the Management of B-Cell-Driven Autoimmune Diseases

3

1

qz.com/astrazeneca-tozorakimab-copd-phase-3-trials-090826

Sep 09

AstraZeneca's experimental COPD drug aced late-stage trials, boosting blockbuster sales hopes

10 similar articles

0

Personalized Respiratory Care: A Path to Better Health for Patients and the Planet

Sep 04

wallstreet-online.de/nachricht/21314827-hoffnung-krebs-astrazeneca-doppel-erfolg-steckt-naechsten-coup

6

1

wotwitt Sep 01

AstraZeneca with a double success: What's behind the next coup: AstraZeneca expands its cancer offensive: A new billion-dollar deal and an important EU ...

boerse-online.de/nachrichten/aktien/diese-laut-morningstar-unterbewerteten-aktien-schuetten-im-september-dividende-aus-20407842.html

5

0

BÖRSE ONLINE

C

Sep 02

These stocks, which Morningstar considers undervalued, are paying dividends in September

Health ministry revokes AstraZeneca Vietnam’s pharmaceutical business certificate

0

news.tuoitre.vn Aug 24

yicaiglobal.com/news/chinas-innocare-pharma-turns-a-profit-in-first-half-due-to-surging-overseas-licensing-revenue

2

0

yicaiglobal.com Aug 28

China’s InnoCare Pharma Turns a Profit in First Half Due to Surging Overseas Licensing Revenue

0

reuters.com/business/healthcare-pharmaceuticals/astrazenecas-asthma-drug-tezspire-meets-all-goals-late-stage-esophagitis-trial-2026-08-27/

Aug 27

AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial: AstraZeneca said on Thursday its asthma drug Tezspire met the main goals ‌of a ...

50

2

South China Morning Post

scmp.com/business/china-business/article/3365384/chinas-akeso-says-cancer-drug-beat-astrazenecas-imfinzi-phase-3-trial

Aug 27

China’s Akeso says cancer drug beat AstraZeneca’s Imfinzi in phase 3 trial: The biliary tract cancer trial is the latest breakthrough for Akeso’s ivonescimab ...

0

Aug 20

Optimizing Clinical Practice in Prostate Cancer

Investor's Business Daily

1

0

D

Aug 03

AstraZeneca Stock Nosedives On Mega-Merger Rumor: AstraZeneca stock took a nosedive Monday amid reports it's mulling a mega-merger with Bristol Myers Squibb ...

investors.com/news/technology/astrazeneca-stock-bristol-myers-squibb-rumored-deal/

29 similar articles

2

0

Aug 17

Gain practical strategies for managing CRSwNP beyond repeated oral steroid use. Learn how current evidence can help identify uncontrolled disease ... Show more

A New Era in Airway Disease Management

7 similar articles

1

0

The Week US

C

Jul 22

The vaccine has been "stockpiled for potential future use", said Sky News. It uses the same mechanism as the Oxford/AstraZeneca Covid-19 vaccine ... Show more

The Week Unwrapped - with Olly Mann

1:18

221

185

Wirtschaftswoche

wiwo.de/finanzen/boerse/astrazeneca-und-bms-deshalb-kommtgroesste-deal-der-geschichte-ueberraschend/100244645.html

Aug 03

AstraZeneca and BMS: Why the biggest deal in history is surprising: The British pharmaceutical company AstraZeneca and its US competitor Bristol Myers Squibb are ...

6 similar articles

13

2

The Market Aug 04

Rumors of a mega-merger between AstraZeneca and BMS unsettle the market: A merger of the two industry giants would instantly create the world's ...

themarket.ch/unternehmen/geruechte-um-megafusion-zwischen-astrazeneca-und-bms-sorgen-fuer-irritationen-ld.17380

2

0

cnbc.com/2026/08/06/astrazeneca-bristol-myers-merger-talks.html

Aug 06

AstraZeneca may buck a decade of pharma strategy to buy U.S. scale: Reports of preliminary talks between AstraZeneca and Bristol Myers Squibb moved shares and ...

22

5

Aug 06

Pharma investors reeled this week from reports that AstraZeneca held merger talks with U.S. rival Bristol Myers Squibb, a move that would break from Big ... Show more

20

7

Senior source denied AstraZeneca and Bristol Myers Squibb were ever in merger talks

Aug 05

0

cnbc.com/2026/08/03/stocks-making-the-biggest-moves-premarket-baba-azn-ebay-more.html

Aug 03

Stocks making the biggest moves premarket: Alibaba, AstraZeneca, eBay & more: These are the stocks posting the largest moves premarket.

36

5

thestreet.com

Aug 05

AstraZeneca-BMY megadeal talk sparks huge market rift Read more: AstraZeneca falls as Bristol Myers rises on merger reports

wallstreet-online.de/nachricht/21153830-zahlen-ueberzeugen-astrazeneca-uebertrifft-erwartungen-krebsmedikamente-treiben-gewinn

0

wotwitt Jul 27

AstraZeneca Exceeds Expectations: Cancer Drugs Drive Profits: July 27, 2026 - The British pharmaceutical company earned significantly more than expected in the ...

4

0

Evolving Therapeutic Strategies for the Management of B-Cell-Driven Autoimmune Diseases

Jul 29

1

0

qz.com/astrazeneca-bristol-myers-squibb-merger-talks-080326

Aug 03

AstraZeneca stock sinks on reports of merger talks with Bristol Myers Squibb: A combination of the two pharmaceutical companies could create an entity valued at ...

3 similar articles

1

0

Financial Times

ft.com/content/eddbdc29-5206-4c79-9ea7-f1a06ff040f1

Aug 03

Struggling to make sense of AstraZeneca-BMS: All about oncology? A cardio workout? Patent-cliff avoidance? American dreaming?

AstraZeneca merging with Bristol Myers would be a big cost-cutting deal: Mizuho's Jared Holz

28

3 0

CNBC Aug 03

0:32

Frankfurter Allgemeine Zeitung

46

3

faz.net/aktuell/wirtschaft/pharma-fusion-von-astra-zeneca-und-bms-keine-traum-hochzeit-201090912.html

Aug 03

OpinionPharma merger of AstraZeneca and BMS: Not a dream match: The stock market is reacting with concern to the rumors of a merger between AstraZeneca and BMS ...

0

Benzinga

Jul 28

Europe’s most valuable company is not a bank, luxury brand or oil giant. It is ASML ($ASML), the Dutch chip equipment leader behind the machines powering the ... Show more

0

1

reuters.com/business/healthcare-pharmaceuticals/astrazeneca-magic-faces-rare-test-after-trial-failure-share-slide-2026-07-24/

Jul 24

Prozess um brutale Schlägerei in Hannovers Rotlichtviertel: Türsteher zu Bewährungsstrafe verurteilt

4

7 4

Optimizing Clinical Practice in Prostate Cancer

Jul 27

1

0

Jul 24

Explore our new curriculum featuring expert-led insights on the latest clinical advances shaping a new era in airway disease management ... Show more

A New Era in Airway Disease Management

3

0

Financial Times

AstraZeneca CEO: ‘Biology will catch up with me at some point’

Jul 12

576

16

thestreet.com

AstraZeneca erases billions after sobering reveal

Jul 13

16 similar articles

0

Investor's Business Daily

D

Jul 14

Biogen Dips As Questions Weigh On Alzheimer's 'Breakthrough': Biogen and Ionis said Tuesday their tau-targeting Alzheimer's treatment slowed cognitive decline by ...

investors.com/news/technology/biogen-ionis-tau-alzheimers-treatment-diranersen/

10 similar articles

0

cnbc.com/2026/07/14/hsbc-astrazeneca-forecasts-tough-path-ahead.html

Jul 14

OpinionHSBC loses conviction in leading drugmaker, forecasts 'tough path' ahead: The bank's analysts wrote in a note on Monday that they have downgraded the stock to ...

27

4

PRecision Oncology: Medical Innovations and Scientific Exchange (PROMISE)

Jul 15

2

0

cnbc.com/2026/07/09/stocks-making-the-biggest-moves-premarket-azn-pep-crm-levi.html

Jul 09

Stocks making the biggest moves premarket: AstraZeneca, PepsiCo, Salesforce, Levi & more

18

6

yorkshirepost.co.uk

yorkshirepost.co.uk/business/astrazeneca-sees-stock-market-value-slump-by-more-than-ps20bn-after-drug-setback-8787029

Jul 10

AstraZeneca sees stock market value slump by more than £20bn after drug setback: AstraZeneca has seen more than £20 billion wiped off its stock market value ...

0

1

Jul 09

Shares of AstraZeneca fell as much as 9% after a late stage clinical trial for an experimental heart disease failed to meet its target. The medicine, Wainua ... Show more

12

5

reuters.com/legal/legalindustry/us-appeals-court-upholds-win-astrazeneca-pfizer-cancer-drug-patent-fight-2026-07-09/

Jul 09

US appeals court upholds win for AstraZeneca in Pfizer cancer drug patent fight: A U.S. appeals court on Thursday upheld a ruling for AstraZeneca against ...

15

5

Chester Standard

chesterstandard.co.uk/news/26261855.equipment-donation-cheshire-college-experience/

Jul 09

Equipment donation to Cheshire College for experience: A donation of five tonnes of specialist equipment will support hands-on training for students.

0

reuters.com/legal/litigation/astrazeneca-daiichi-near-uk-pricing-deal-breast-cancer-drug-bloomberg-news-2026-07-08/

Jul 08

AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports

statnews.com/pharmalot/2026/07/08/fda-approves-vera-kidney-drug-uk-enhertu-pricing-deal/

4

STAT Jul 08

Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and more

0

The Wall Street Journal

wsj.com/health/pharma/astrazeneca-sino-biopharm-sign-up-to-1-9-billion-respiratory-drug-licensing-deal-1c7d7a08

Jul 08

AstraZeneca, Sino Biopharm Sign Up to $1.9 Billion Respiratory Drug Licensing Deal

2

1

reuters.com/world/uk/britains-ftse-indexes-slip-miners-offset-financial-gains-2026-07-06/

Jul 06

Britain's FTSE 100 slips as miners, healthcare losses weigh: London's FTSE 100 ended lower on Monday as losses in precious metal miners and ‌drugmakers ...

12

1

Comprehensive Approach to Lipid Management in CV Risk Reduction and Beyond

Jul 02

3 similar articles

4

0

wotwitt Jun 29

OpinionThis decision opens up a new billion-dollar market for AstraZeneca: A new EU approval significantly expands the use of an important cancer drug ...

wallstreet-online.de/nachricht/21051951-eu-gruenes-licht-beschluss-astrazeneca-milliardenmarkt

2

0

reuters.com/legal/litigation/astrazeneca-signs-cspc-china-deal-experimental-kidney-disease-drugs-2026-07-02/

Jul 02

AstraZeneca signs CSPC China deal for experimental kidney disease drugs: AstraZeneca has entered into a deal worth up to $1.77 billion with CSPC ‌Pharmaceutical ...

statnews.com/pharmalot/2026/06/29/astrazeneca-kickback-charges-texas-settlement/

7

4

STAT Jun 30

AstraZeneca to pay $34 million to settle kickback charges filed by Texas attorney general

thetimes.com/business/companies-markets/article/london-stock-exchange-ftse-new-york-02zcx9src

0

The Times and The Sunday Times Jun 27

Flight risk fears for 20 FTSE giants that could move to New York: After AstraZeneca took a direct US listing, LSE says up to 20 blue-chip companies could follow ...

42

59

The Independent

independent.co.uk/news/health/weight-loss-pill-astrazeneca-elecoglipron-b2992977.html

Jun 10

New daily weight loss pill elecoglipron helps people shed 10 per cent of body weight

wionews.com/science/next-weight-loss-breakthrough-astrazeneca-tests-a-daily-pill-1780986473092

18

7

WION

C

Jun 10

Next weight-loss breakthrough? AstraZeneca tests a daily pill - Elepeglitron: AstraZeneca’s daily weight-loss pill elecoglipron delivers 11.8% body weight ...

3

0

cnbc.com/2026/06/05/astrazeneca-ceo-says-ai-is-reshaping-drug-development-and-helping-boost-the-odds-of-success.html

Jun 06

AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success

36

3 32

The Times

thetimes.com/uk/healthcare/article/astrazeneca-weight-loss-pills-uk-xwtfr5w3r

Jun 08

AstraZeneca joins race to bring weight-loss pills to the UK: Millions of patients have joined waiting lists for orally administered weight-loss tablets ...